Three-dimensional in vivo monitoring of mycobacterial infections and therapeutic efficacy based on tissue-clearing technology CUBIC

Author:

Hakamata Mariko1,Nishiyama Akihito1,Inouchi Erina1,Yokoyama Akira1,Kaboso Shaban A.1,Gebretsadik Gebremichal1,Yamasaki Tomoya1,Moro Hiroshi1,Ozeki Yuriko1,Tateishi Yoshitaka1,Ohashi Riuko1,Primm Todd P.2,Kikuchi Toshiaki1,Tainaka Kazuki1,Matsumoto Sohkichi1

Affiliation:

1. Niigata University School of Medicine

2. Sam Houston State University

Abstract

Abstract Mycobacteria are a continuous threat to human health. They include various species, such as Mycobacterium tuberculosis (M. tuberculosis), which is an intracellular parasite of mammals, and the most virulent and non-tuberculous mycobacteria (NTM), namely, M. avium, which are environmental bacteria causing intractable NTM diseases. An infection model of transparent zebrafish and fish-infectious M. marinum was established to better understand the in vivo behavior of mycobacteria under the pressure of host immune responses. However, the fish model does not fully replicate mammalian immunity. Here, we demonstrate that a clear, unobstructed brain/body imaging cocktail and computational analysis (CUBIC)-based infection (CUBIC-infection) analysis enables comprehensive mycobacterial profiling of the whole lung. We assessed the in vivo kinetics of mycobacterial infection along with fluorescent protein-expressing recombinant mycobacteria. We detected mycobacterium at a single bacterial level and counted bacterial numbers, which was comparable to the colony-forming units of organ homogenates. CUBIC-infection analysis distinguished in vivo spatiotemporal behavior of M. tuberculosis, M. tuberculosisvariant Bacillus Calmette-Guerin, and M. avium in mice. Furthermore, it monitored spatiotemporal information on the therapeutic efficacies of anti-tuberculosis drugs and an anti-lymphangiogenesis agent. Our data suggest that CUBIC-infection analysis is a powerful tool for understanding mycobacterial infections in mammals and developing therapeutic agents.

Publisher

Research Square Platform LLC

Reference44 articles.

1. World Health Organization. Global Tuberculosis Report 2021 (WHO, Geneva, Switzerland, 2020).

2. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies;Tiberi S;Lancet Infect. Dis.,2018

3. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins;Karkkainen MJ;Nat. Immunol.,2004

4. Molecular biology and pathology of lymphangiogenesis;Karpanen T;Annu. Rev. Pathol.,2008

5. Biology of vascular endothelial growth factors;Roy H;FEBS Lett.,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3